• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

16.78 -0.75 (-4.28%)
Official Closing Price Updated: 7:00 PM EDT, May 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,855,890
Open 17.45
Bid (Size) 16.75 (1)
Ask (Size) 16.97 (10)
Prev. Close 17.53
Today's Range 16.70 - 17.47
52wk Range 12.46 - 22.80
Shares Outstanding 1,110,352,397
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
May 30, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with
May 30, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire

Performance

YTD
-21.2%
-21.2%
1 Month
+11.7%
+11.7%
3 Month
N/A
N/A
6 Month
+0.5%
+0.5%
1 Year
+0.1%
+0.1%

More News

Read More
Where Teva Pharmaceutical Indus Stands With Analysts
May 28, 2025
Via Benzinga
Teva Reaffirms Growth Strategy, Eyes $5 Billion Innovative Franchise By 2030
May 29, 2025
Via Benzinga
Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day
May 29, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Billionaire Stanley Druckenmiller Just Sold One of Wall Street's Hottest Stock-Split Stocks and Is Piling Into a Promising Drugmaker Instead
May 28, 2025
Via The Motley Fool
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence Interest Rates Political
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
May 27, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
May 27, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Why Is Teva Stock Trading Higher On Tuesday?
May 27, 2025
Via Benzinga
Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma
May 27, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes
May 22, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt
May 20, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy
May 20, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031
May 19, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes
May 19, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
May 15, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Why Teva Pharmaceuticals Stock Blasted 6% Higher Today
May 12, 2025
Via The Motley Fool
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
May 12, 2025
Via Benzinga
This Wayfair Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
May 12, 2025
Via Benzinga
Teva’s 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy
May 12, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Why Teva Pharmaceutical Stock Is Soaring Today
May 07, 2025
Via The Motley Fool
Topics Earnings Stocks
Exposures Financial US Equities
Teva Shares Climb On Profit Beat, $700 Million Cost Plan, Biopharma Pivot Momentum
May 07, 2025
Via Benzinga
Teva Surges On Profit Guidance Boost Despite A Mixed First-Quarter Report
May 07, 2025
Via Investor's Business Daily
Topics Government
Exposures Political
Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved
May 07, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City
May 07, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire

Frequently Asked Questions

Is Teva Pharmaceutical Industries Limited American Depositary Shares publicly traded?
Yes, Teva Pharmaceutical Industries Limited American Depositary Shares is publicly traded.
What exchange does Teva Pharmaceutical Industries Limited American Depositary Shares trade on?
Teva Pharmaceutical Industries Limited American Depositary Shares trades on the New York Stock Exchange
What is the ticker symbol for Teva Pharmaceutical Industries Limited American Depositary Shares?
The ticker symbol for Teva Pharmaceutical Industries Limited American Depositary Shares is TEVA on the New York Stock Exchange
What is the current price of Teva Pharmaceutical Industries Limited American Depositary Shares?
The current price of Teva Pharmaceutical Industries Limited American Depositary Shares is 16.78
When was Teva Pharmaceutical Industries Limited American Depositary Shares last traded?
The last trade of Teva Pharmaceutical Industries Limited American Depositary Shares was at 05/30/25 07:00 PM ET
What is the market capitalization of Teva Pharmaceutical Industries Limited American Depositary Shares?
The market capitalization of Teva Pharmaceutical Industries Limited American Depositary Shares is 18.63B
How many shares of Teva Pharmaceutical Industries Limited American Depositary Shares are outstanding?
Teva Pharmaceutical Industries Limited American Depositary Shares has 19B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap